ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $2,521,000 | +5.9% | 6,880,252 | +59.0% | 0.00% | – |
Q1 2019 | $2,381,000 | +11.0% | 4,328,450 | 0.0% | 0.00% | – |
Q4 2018 | $2,146,000 | -39.0% | 4,328,450 | 0.0% | 0.00% | – |
Q3 2018 | $3,517,000 | -13.6% | 4,328,450 | -3.3% | 0.00% | – |
Q2 2018 | $4,072,000 | -65.7% | 4,474,309 | -0.2% | 0.00% | -100.0% |
Q1 2018 | $11,877,000 | -24.0% | 4,481,874 | +0.4% | 0.00% | -50.0% |
Q4 2017 | $15,623,000 | -21.3% | 4,463,752 | +13.5% | 0.00% | 0.0% |
Q3 2017 | $19,852,000 | +61.7% | 3,931,123 | +10.5% | 0.00% | 0.0% |
Q2 2017 | $12,274,000 | -1.4% | 3,557,779 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $12,452,000 | +62.8% | 3,557,779 | 0.0% | 0.00% | +100.0% |
Q4 2016 | $7,649,000 | -32.4% | 3,557,779 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $11,314,000 | +14.4% | 3,557,779 | +0.0% | 0.00% | +100.0% |
Q2 2016 | $9,890,000 | -29.3% | 3,557,652 | +0.2% | 0.00% | -50.0% |
Q1 2016 | $13,993,000 | -59.9% | 3,551,596 | +0.1% | 0.00% | -60.0% |
Q4 2015 | $34,870,000 | -4.2% | 3,547,261 | +0.0% | 0.01% | 0.0% |
Q3 2015 | $36,381,000 | -44.6% | 3,545,892 | +0.0% | 0.01% | -37.5% |
Q2 2015 | $65,657,000 | – | 3,545,181 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $18,755,000 | 12.78% |
EcoR1 Capital, LLC | 840,462 | $8,623,000 | 3.92% |
Rock Springs Capital Management LP | 388,996 | $3,991,000 | 0.32% |
SPHERA FUNDS MANAGEMENT LTD. | 209,027 | $2,145,000 | 0.27% |
Baker Brothers Advisors | 2,335,125 | $23,958,000 | 0.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 461,530 | $4,735,000 | 0.18% |
TIVERTON ASSET MANAGEMENT LLC | 472,236 | $4,845,000 | 0.11% |
RS INVESTMENT MANAGEMENT CO LLC | 1,082,249 | $11,104,000 | 0.10% |
RIVERHEAD CAPITAL MANAGEMENT LLC | 415,377 | $4,262,000 | 0.07% |
Magnetar Financial LLC | 354,659 | $3,639,000 | 0.05% |